Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
As of today, Collegium Pharmaceutical(COLL) shares are valued at $42.30. The company's market cap stands at 1.33B, with a P/E ratio of 39.25.
As of 2025-11-07, Collegium Pharmaceutical(COLL) stock has fluctuated between $40.00 and $43.06. The current price stands at $42.30, placing the stock +5.7% above today's low and -1.8% off the high.
The Collegium Pharmaceutical(COLL)'s current trading volume is 851.88K, compared to an average daily volume of 458.93K.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $43.06 and a 52-week low of $23.23.
In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $43.06 and a 52-week low of $23.23.
COLL News
Earnings Call Insights Collegium anticipates 24% revenue growth in 2025 with Jornay PM driving expansion Nov. 06, 2025 10:06 PM ET Collegium Pharmaceutical, Inc...
(RTTNews) - Collegium Pharmaceutical, Inc. (COLL) gained 12.20% to $40.22, up $4.38, after reporting strong third-quarter 2025 results and raising its full-year...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...